News this am: "Applied DNA Sciences to Lead Panel and DNA Marking Workshop at ERAI Executive Conference".
This PR should give the stock a bit of a boost this morning.
"Applied DNA Sciences to Lead Panel and DNA Marking Workshop at ERAI Executive Conference
Orlando, FL, April 18-19, 2013
STONY BROOK, NY--(Marketwired - Apr 17, 2013) - Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that senior managers will lead important meetings this week concerning the company's SigNature® DNA marking program for electronics, currently required by the Defense Logistics Agency (DLA) for Federal Supply Class (FSC) 5962 microcircuits. The APDN SigNature DNA marking technology, which forensically protects against counterfeiting, has been gaining excitement and attention throughout the electronics industry. The platform will be explained by its most knowledgeable experts.
Janice Meraglia, Vice President of Government and Military Programs, and Bob MacDowell, Senior Sales Representative, will lead a workshop describing SigNature DNA marking. At a panel discussion focused on critical issues surrounding traceability in the supply chain, scheduled speakers are Dr. James A. Hayward, CEO and President of Applied DNA Sciences, Christine Metz, Chief of the Technical and Quality Policy Division for DLA Logistics Operations (Defense Logistics Agency), Tom Sharpe, Vice President of SMT Corp., Dave Loaney, CEO of Premier Semiconductor Service, and John Tomaszewicz, Quality Assurance Manager, Avnet USI. Please see below for time and place of these events.
"Signature DNA has been the subject of countless articles, meetings, blog posts and comments," observed Ms. Meraglia, "This is a chance to understand the platform factually and objectively, from the people who created it."
yes, the best this company can do is announce a participation in a workshop, have they announced any new deals this year?...no, and why is that?...maybe because at this stage nobody cares about that DNA marking because it is too damn expensive to use them...but keep reading penny stock news letters and keep holding the bag..lol
Good info. But investors are looking for REVENUE, in the absence of which I look forward to a much lower get-back-in-again point, not sure about .12-.13, but definitely below .15. Got out somewhere above .19, good move in retrospect. There is an unfilled gap around .13, watchfull.